Cargando…

Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids

BACKGROUND: Cationic antimicrobial peptides (CAMPs) are attractive scaffolds for the next generation of antimicrobial compounds, due to their broad spectrum of activity against multi-drug resistant bacteria and the reduced fitness of CAMP-insensitive mutants. Unfortunately, they are limited by poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Findlay, Brandon, Szelemej, Paul, Zhanel, George G., Schweizer, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402541/
https://www.ncbi.nlm.nih.gov/pubmed/22844435
http://dx.doi.org/10.1371/journal.pone.0041141
_version_ 1782238770342395904
author Findlay, Brandon
Szelemej, Paul
Zhanel, George G.
Schweizer, Frank
author_facet Findlay, Brandon
Szelemej, Paul
Zhanel, George G.
Schweizer, Frank
author_sort Findlay, Brandon
collection PubMed
description BACKGROUND: Cationic antimicrobial peptides (CAMPs) are attractive scaffolds for the next generation of antimicrobial compounds, due to their broad spectrum of activity against multi-drug resistant bacteria and the reduced fitness of CAMP-insensitive mutants. Unfortunately, they are limited by poor in vivo performance, including ready cleavage by endogenous serum proteases. METHODOLOGY/PRINCIPAL FINDINGS: To explore the potential for peptoid residues to replace well studied CAMP scaffolds we have produced a series of antimicrobial lipopeptoids, with sequences similar to previously reported lipopeptides. The activity of the peptoids was assessed against a panel of clinically relevant and laboratory reference bacteria, and the potential for non-specific binding was determined through hemolytic testing and repeating the antimicrobial testing in the presence of added bovine serum albumin (BSA). The most active peptoids displayed good to moderate activity against most of the Gram positive strains tested and moderate to limited activity against the Gram negatives. Antimicrobial activity was positively correlated with toxicity towards eukaryotic cells, but was almost completely eliminated by adding BSA. CONCLUSION/SIGNIFICANCE: The lipopeptoids had similar activities to the previously reported lipopeptides, confirming their potential to act as replacement, proteolytically stable scaffolds for CAMPs.
format Online
Article
Text
id pubmed-3402541
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34025412012-07-27 Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids Findlay, Brandon Szelemej, Paul Zhanel, George G. Schweizer, Frank PLoS One Research Article BACKGROUND: Cationic antimicrobial peptides (CAMPs) are attractive scaffolds for the next generation of antimicrobial compounds, due to their broad spectrum of activity against multi-drug resistant bacteria and the reduced fitness of CAMP-insensitive mutants. Unfortunately, they are limited by poor in vivo performance, including ready cleavage by endogenous serum proteases. METHODOLOGY/PRINCIPAL FINDINGS: To explore the potential for peptoid residues to replace well studied CAMP scaffolds we have produced a series of antimicrobial lipopeptoids, with sequences similar to previously reported lipopeptides. The activity of the peptoids was assessed against a panel of clinically relevant and laboratory reference bacteria, and the potential for non-specific binding was determined through hemolytic testing and repeating the antimicrobial testing in the presence of added bovine serum albumin (BSA). The most active peptoids displayed good to moderate activity against most of the Gram positive strains tested and moderate to limited activity against the Gram negatives. Antimicrobial activity was positively correlated with toxicity towards eukaryotic cells, but was almost completely eliminated by adding BSA. CONCLUSION/SIGNIFICANCE: The lipopeptoids had similar activities to the previously reported lipopeptides, confirming their potential to act as replacement, proteolytically stable scaffolds for CAMPs. Public Library of Science 2012-07-23 /pmc/articles/PMC3402541/ /pubmed/22844435 http://dx.doi.org/10.1371/journal.pone.0041141 Text en Findlay et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Findlay, Brandon
Szelemej, Paul
Zhanel, George G.
Schweizer, Frank
Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids
title Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids
title_full Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids
title_fullStr Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids
title_full_unstemmed Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids
title_short Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids
title_sort guanidylation and tail effects in cationic antimicrobial lipopeptoids
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402541/
https://www.ncbi.nlm.nih.gov/pubmed/22844435
http://dx.doi.org/10.1371/journal.pone.0041141
work_keys_str_mv AT findlaybrandon guanidylationandtaileffectsincationicantimicrobiallipopeptoids
AT szelemejpaul guanidylationandtaileffectsincationicantimicrobiallipopeptoids
AT zhanelgeorgeg guanidylationandtaileffectsincationicantimicrobiallipopeptoids
AT schweizerfrank guanidylationandtaileffectsincationicantimicrobiallipopeptoids